Presence of Epstein-Barr virus DNA in tonsillar tissues.
Sera from 48 tonsillar carcinoma (TC) patients, 48 matched controls and 16 recurrent exudative tonsillitis (RET) patients were examined for the presence of Epstein-Barr virus (EBV) associated nuclear antigen (EBNA), early antigen (EA) and virus capsid antigen (VCA). Higher prevalence and significantly higher antibody titres against all three EBV-associated antigens were observed in TC patients in comparison with controls and RET patients. Patients suffering from anaplastic TC had higher titres of antibodies against VCA and EA than TC patients with other histological diagnoses. Five out of 11 TC biopsies obtained from 9 patients were positive for EBV DNA at levels of 0.17, 4 to 5, 15 to 18 and in two cases 3 EBV genome equivalents per cellular genome. Among 16 RET patients, 4 were found positive at levels not exceeding 2.17 EBV genome equivalents per cellular genome. Higher titres of antibody against all EBV antigens were found in TC and RET patients with EBV DNA-positive tonsillar tissue than in those with EBV DNA-negative tonsillar tissue.
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000032:analysis*; D004279:DNA, Viral / Q000032:analysis*; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D008875:Middle Aged; D009693:Nucleic Acid Hybridization; D014067:Tonsillar Neoplasms / Q000032:analysis*; D014069:Tonsillitis / Q000378:metabolism
D000914:Antibodies, Viral; D000956:Antigens, Viral; D004279:DNA, Viral